Literature DB >> 34308410

Post-COVID syndrome: Turning convalescence into illness? - Authors' reply.

Max Augustin1, Clara Lehmann1.   

Abstract

Entities:  

Year:  2021        PMID: 34308410      PMCID: PMC8275030          DOI: 10.1016/j.lanepe.2021.100170

Source DB:  PubMed          Journal:  Lancet Reg Health Eur        ISSN: 2666-7762


× No keyword cloud information.
We have carefully read the reply letter by Doctores Cozzi, Amaddeo and Barbi [1] to our research paper titled “Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study” [2] and note that a disruptive event such as the pandemic can promote the development of somatoform symptoms in predisposed individuals. We agree that there is a danger in seeking health care that somatoform symptoms may instead be exacerbated, with the risk of convalescence becoming illness. Convalescence from COVID-19 can take a lengthy course over months resulting in great societal and economic consequences. We found anosmia, ageusia, shortness of breath and fatigue to be the most common persisting symptom up to 7 months after symptom onset. Here, specific symptoms face nonspecific symptoms, physical health faces mental health. Especially with regard to fatigue, a holistic approach is necessary to reduce bias. It is undisputed that the aggravating circumstances such as social distancing and frequently changing narratives pose a particular challenge in terms of mental health and coping strategies. This is precisely when it is important to perceive patient impressions, to put them into perspective and to examine them in a multidisciplinary manner, as we did with 958 SARS-CoV-2 convalescents. It is important to emphasize that all post-COVID symptoms reported were newly emerged and resulted in restrictions of everyday life. Thus, a differentiated and critical anamnesis is essential to assess the symptoms in order to finally make the clinical diagnosis of a post-COVID syndrome and furthermore to provide support and offer solutions with the aim of shortening time of convalescence. Taken together, we don't think critically evaluating and labelling health consequences after viral illness is about turning convalescence into illness but rather about labelling illness to accelerate convalescence.

Author contribution

MA an CL contributed to all aspects of the Letter.

Declaration of Competing Interests

MA and CL have nothing to disclose.
  2 in total

1.  Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study.

Authors:  Max Augustin; Philipp Schommers; Melanie Stecher; Felix Dewald; Lutz Gieselmann; Henning Gruell; Carola Horn; Kanika Vanshylla; Veronica Di Cristanziano; Luise Osebold; Maria Roventa; Toqeer Riaz; Nikolai Tschernoster; Janine Altmueller; Leonard Rose; Susanne Salomon; Vanessa Priesner; Jan Christoffer Luers; Christian Albus; Stephan Rosenkranz; Birgit Gathof; Gerd Fätkenheuer; Michael Hallek; Florian Klein; Isabelle Suárez; Clara Lehmann
Journal:  Lancet Reg Health Eur       Date:  2021-05-18

2.  Post-COVID syndrome: Turning convalescence into illness?

Authors:  Giorgio Cozzi; Alessandro Amaddeo; Egidio Barbi
Journal:  Lancet Reg Health Eur       Date:  2021-07-06
  2 in total
  3 in total

1.  Obesity and lipid metabolism disorders determine the risk for development of long COVID syndrome: a cross-sectional study from 50,402 COVID-19 patients.

Authors:  Sven H Loosen; Björn-Erik Ole Jensen; Tom Luedde; Christoph Roderburg; Karel Kostev; Christian Tanislav
Journal:  Infection       Date:  2022-03-30       Impact factor: 7.455

2.  COVAD survey 2 long-term outcomes: unmet need and protocol.

Authors:  Rohit Aggarwal; Latika Gupta; Zoha Zahid Fazal; Parikshit Sen; Mrudula Joshi; Naveen Ravichandran; James B Lilleker; Vishwesh Agarwal; Sinan Kardes; Minchul Kim; Jessica Day; Ashima Makol; Marcin Milchert; Tamer Gheita; Babur Salim; Tsvetelina Velikova; Abraham Edgar Gracia-Ramos; Ioannis Parodis; Elena Nikiphorou; Ai Lyn Tan; Tulika Chatterjee; Lorenzo Cavagna; Miguel A Saavedra; Samuel Katsuyuki Shinjo; Nelly Ziade; Albert Selva-O'Callaghan; Arvind Nune; Johannes Knitza; Masataka Kuwana; Carlos-Enrique Toro Gutiérrez; Carlo Vinicio Caballero-Uribe; Dzifa Dey; Oliver Distler; Hector Chinoy; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2022-08-14       Impact factor: 3.580

3.  Predictors of post-COVID-19 and the impact of persistent symptoms in non-hospitalized patients 12 months after COVID-19, with a focus on work ability.

Authors:  Marta A Kisiel; Helena Janols; Tobias Nordqvist; Jonas Bergquist; Simone Hagfeldt; Andrei Malinovschi; Magnus Svartengren
Journal:  Ups J Med Sci       Date:  2022-08-09       Impact factor: 2.646

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.